Disease | hypertriglyceridemia |
Comorbidity | C0011847|diabetes |
Sentences | 21 |
PubMedID- 21532777 | A survey conducted in >8000 patients receiving treatment for dyslipidaemia, (mostly with a statin) in 11 european countries confirmed a higher prevalence of low hdl-c and/or hypertriglyceridaemia in patients with type 2 diabetes, relative to patients without diabetes (table 1) [13, 14]. |
PubMedID- 25725623 | The characteristic hypertriglyceridaemia observed in patients with type 2 diabetes stimulates cetp, leading to the preferential formation of triacylglycerol-rich small, dense ldl particles over larger ones [74]. |
PubMedID- 20398338 | The nile rat fed typical rodent diets develops hyperinsulinemia that precedes hyperglycemia (insulin resistance) leading to diet-induced type 2 diabetes associated with hypertriglyceridemia, hypercholesterolemia, and hypertension. |
PubMedID- 21477296 | Among patients with type 2 diabetes the combination of abdominal enlargement and hypertriglyceridemia, so-called hypertriglyceridemic waist (hw), is highly prevalent [2] and has been associated with a greater degree of subclinical atherosclerosis that may be related to the proatherogenic lipoprotein changes [3,4]. |
PubMedID- 23365565 | In alloxan-induced diabetes, hyperglycemia is associated with hypertriglyceridemia and hypercholesterolemia [18]. |
PubMedID- 25035662 | Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with diabetes mellitus. |
PubMedID- 24164719 | hypertriglyceridemia is commonly associated with diabetes, obesity, hypertension, and smoking, which are independent risk factors for chd [24,25]. |
PubMedID- 23734746 | Background: postprandial hypertriglyceridemia in diabetes mellitus can be followed by endothelial dysfunction, impaired vascular compliance and increased cardiovascular complications. |
PubMedID- 20537932 | Conclusion: there was a significant discordance between ldl and non-hdl cholesterol levels in diabetes patients with high triglycerides or the ms. |
PubMedID- 25573251 | Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridaemia in patients with type 2 diabetes mellitus20. |
PubMedID- 20722684 | Severe hypertriglyceridaemia is associated with uncontrolled diabetes, obesity and poor physical activity. |
PubMedID- 25617537 | This literature review discusses the safety on glucose metabolism of n-3 pufa supplementation in the treatment of hypertriglyceridemia in subjects with type 2 diabetes mellitus. |
PubMedID- 23408779 | The most common dyslipidemia in diabetes is the combination of high triglycerides and low hdl levels. |
PubMedID- 22224930 | Even though insulin resistance, cardiovascular disease (cvd), and type 2 diabetes (t2d) are associated with hypertriglyceridemia, blacks with these conditions usually have normal triglyceride (tg) levels. |
PubMedID- 21630032 | Moreover, because hypertriglyceridemia is often associated with obesity, diabetes, metabolic syndrome, increased cholesterol levels, disturbed hemostasis and inflammation, some researchers assume that elevated triglyceride levels may be only a non-causal biomarker of future cardiovascular risk [7]. |
PubMedID- 21510110 | Post-prandial hypertriglyceridemia in patients with type 2 diabetes mellitus with and without macrovascular disease. |
PubMedID- 22675253 | Recent findings indicate that apoa5 could also influence cholesterol homeostasis and probably play a role in hypertriglyceridemia associated with diabetes and inflammation [20]. |
PubMedID- 23853615 | Raised tg levels, small low density lipoprotein-cholesterol (ldl-c) particles, and low hdl-c (22)); low hdl-c was a component of mets only in the presence of hypertriglyceridemia in patients with type 2 diabetes mellitus (10). |
PubMedID- 24684850 | Recent findings indicate that apoa5 could also influence cholesterol homeostasis and probably could play a role in hypertriglyceridemia associated with diabetes and inflammation [11]. |
PubMedID- 24876549 | Saroglitazar appeared to be an effective and safe therapeutic option for improving hypertriglyceridemia in patients with type 2 diabetes mellitus. |
PubMedID- 26291068 | Decreased vldl-apo b 100 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy. |
Page: 1